Unicharm (OTCMKTS:UNICY – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.04 earnings per share for the quarter, Zacks reports. Unicharm had a net margin of 6.33% and a return on equity of 6.85%.
Unicharm Stock Performance
Unicharm stock traded down $0.28 during trading hours on Wednesday, reaching $2.85. 40,714 shares of the stock were exchanged, compared to its average volume of 425,009. Unicharm has a 52-week low of $2.61 and a 52-week high of $3.67. The stock has a market cap of $9.92 billion, a P/E ratio of 23.75 and a beta of 0.31. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.06 and a current ratio of 2.57. The firm’s 50 day moving average is $2.92 and its 200 day moving average is $3.01.
Analyst Ratings Changes
Separately, Zacks Research cut Unicharm from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy”.
About Unicharm
Unicharm Corporation is a Tokyo‐based consumer goods company founded in 1961. Specializing in hygiene and care products, the firm has built its reputation on developing innovative, high-performance solutions for everyday needs. Over more than six decades, Unicharm has grown from a domestic manufacturer to a leading global player in the personal care industry.
The company’s core business activities encompass the design, production and marketing of disposable hygiene products. Key product lines include baby care items such as diapers and training pants; feminine hygiene products including sanitary napkins and panty liners; adult incontinence solutions; and pet care offerings like pet diapers and wet wipes.
Further Reading
- Five stocks we like better than Unicharm
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.
